Fluorine-18 fluorodeoxyglucose positron emission tomography in the differential diagnosis of pancreatic carcinoma: A report of 106 cases

European Journal of Nuclear Medicine

Volumn 24, Issue 6, 1997, Pages 678-682

  Zimny, Michael ^a,b   Bares, Roland ^a   Faß, Jürgen ^a   Adam, Gerhard ^a   Cremerius, Uwe ^a   Dohmen, Bernhard ^a   Klever, Peter ^a   Sabri, Osama ^a   Schumpelick, Volker ^a   Buell, Udalrich ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Diabetes mellitus; Fluorine 18 fluorodeoxyglucose; Pancreatic carcinoma; Positron emission tomography

Indexed keywords

FLUORINE 18; FLUORODEOXYGLUCOSE; GLUCOSE;

ADULT; AGED; ARTICLE; CHRONIC PANCREATITIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE UTILIZATION; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PANCREAS CARCINOMA; POSITRON EMISSION TOMOGRAPHY;

ADENOCARCINOMA; BLOOD GLUCOSE; CHRONIC DISEASE; DEOXYGLUCOSE; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PANCREATITIS; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 8544283014     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050106     Document Type: Article

References (12)

1. Bakkevold KE, Arnesjo B, Kambestad B. Carcinoma of the pancreas and papilla of Vater - assessment of resectability and factors influencing resectability in stage I carcinomas. A prospective multicentre trial in 472 patients. Eur J Surg Oncol 1992; 18: 494-507 .
2. DelMaschio A, Vanzulli A, Sironi S, Castrucci M, Mellone R, Staudacher C, Carlucci M, Zerbi A, Parolini D, Faravelli A, Cantaboni A, Garancini P, Di Carlo V. Pancreatic cancer versus chronic pancreatitis: diagnosis with Ca 19-9 assessment, US, CT, and CT-guided fine needle biopsy. Radiology 1991; 178: 95-99.
3. Bryde-Andersen H, Efferson H, Tjalve E, Burcharth F. CT for assessment of pancreatic and periampullary cancer. Acta Radiol 1993; 34: 569-572.
4. Inokuma T, Tamaki N, Torizuka T, Fujita T, Magata Y, Yonekura Y, Ohshio G, Imamura M, Konishi J. Evaluation of pancreatic tumors with positron emission tomography and F-18 fluordeoxyglucose: comparison with CT and US. Radiology 1995; 195: 345-352.
5. Kato T, Hiroshi F, Ito K, Tadokoro M, Ota T, Ikeda M, Isomura T, Ito S, Nishino M, Ishigaki T. Fluorodeoxyglucose positron emission tomography in pancreatic cancer: an unsolved problem. Eur J Nucl Med 1995; 22: 32-39.
6. Stollfuss JC, Glatting G, Friess H, Kocher F, Beger HG, Reske SN. 2-(fluorine-18)-fluoro-2-deoxy-D-glucose PET in detection of pancreatic cancer: value of quantitative image interpretation. Radiology 1995; 195: 339-344.
7. Bares R, Klever P, Hauptmann S, Hellwig D, Fass J, Cremerius U, Schumpelick V, Mittermeyer C, Buell U, F-18 fluorodeoxyglucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer. Radiology 1994; 192: 79-86.
8. Bares R, Dohmen BM, Cremerius U, Faß J, Teusch M, Büll U. Ergebnisse der Positronenemmissionstomographie mit Fluor-18-markierter Fluordeoxyglucose bei Differentialdiagnose und Staging des Pankreaskarzinoms. Radiologe 1996; 36: 435-440.
9. Rigo P, Paulus P, Kaschten BJ, Hustinx R, Bury T, Jerusalem G, Benoit T, Foidart-Willems J. Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose. Eur J Nucl Med 1996; 23: 1641-1674.
10. Warburg W. The metabolism of tumors. New York: RR Smith; 1931: 129-169.
11. Brown RS, Wahl RL. Overexpression of glut-1 glucose transporter in human breast cancer. Cancer 1993; 72: 2979-2985.
12. Wahl RL, Henry CA, Ethier SP. Serum glucose: effects on tumor and normal tissue accumulation of 2-[F-18]-fluoro-2-deoxy-glucose in rodents with mammary carcinoma. Radiology 1992; 183: 643-647.